Tytuł pozycji:
The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial.
-
Tytuł:
-
The Association of Fenofibrate with Kidney Tubular Injury in a Subgroup of Participants in the ACCORD Trial.
-
Autorzy:
-
Chauhan K; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Nadkarni GN; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Debnath N; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Chan L; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Saha A; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Garg AX; Institute for Clinical Evaluative Sciences, Toronto, Canada.; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada; and.
Parikh CR; Division of Nephrology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.
Coca SG; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
-
Źródło:
-
Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2019 Oct 07; Vol. 14 (10), pp. 1521-1523. Date of Electronic Publication: 2019 Aug 13.
-
Typ publikacji:
-
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2023- : Hagerstown, MD : Wolters Kluwer Health
Original Publication: Washington, D.C. : American Society of Nephrology, c2005-
-
MeSH Terms:
-
Kidney Tubules*
Diabetes Mellitus, Type 2/*drug therapy
Fenofibrate/*adverse effects
Hypolipidemic Agents/*adverse effects
Kidney Diseases/*chemically induced
Aged ; Biomarkers/urine ; Diabetes Mellitus, Type 2/urine ; Female ; Humans ; Hypolipidemic Agents/therapeutic use ; Kidney Diseases/urine ; Male ; Middle Aged
-
References:
-
Jun M, Zhu B, Tonelli M, Jardine MJ, Patel A, Neal B, Liyanage T, Keech A, Cass A, Perkovic V: Effects of fibrates in kidney disease: A systematic review and meta-analysis. J Am Coll Cardiol 60: 2061–2071, 2012 23083786.
Mottl AK, Buse JB, Ismail-Beigi F, Sigal RJ, Pedley CF, Papademetriou V, Simmons DL, Katz L, Mychaleckyj JC, Craven TE: Long-term effects of intensive glycemic and blood pressure control and fenofibrate use on kidney outcomes. Clin J Am Soc Nephrol 13: 1693–1702, 2018 30361335.
Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group: Effects of intensive blood pressure lowering on kidney tubule injury in CKD: A longitudinal subgroup analysis in SPRINT. Am J Kidney Dis 73: 21–30, 2019 30291012.
Nadkarni GN, Chauhan K, Rao V, Ix JH, Shlipak MG, Parikh CR, Coca SG: Effect of intensive blood pressure lowering on kidney tubule injury: Findings from the ACCORD trial study participants. Am J Kidney Dis 73: 31–38, 2019 30291011.
Mychaleckyj JC, Craven T, Nayak U, Buse J, Crouse JR, Elam M, Kirchner K, Lorber D, Marcovina S, Sivitz W, Sperl-Hillen J, Bonds DE, Ginsberg HN: Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants. Diabetes Care 35: 1008–1014, 2012 22432114.
-
Grant Information:
-
UL1 TR001863 United States TR NCATS NIH HHS; R01 DK096549 United States DK NIDDK NIH HHS; U01 DK106962 United States DK NIDDK NIH HHS
-
Contributed Indexing:
-
Keywords: Fenofibrate; Kidney Tubular Injury; Urine Biomarkers; hypolipidemic agents; kidney
-
Substance Nomenclature:
-
0 (Biomarkers)
0 (Hypolipidemic Agents)
U202363UOS (Fenofibrate)
-
Entry Date(s):
-
Date Created: 20190815 Date Completed: 20201123 Latest Revision: 20230421
-
Update Code:
-
20240104
-
PubMed Central ID:
-
PMC6777587
-
DOI:
-
10.2215/CJN.00370119
-
PMID:
-
31409596
-